Selective targeting of B cells with agonistic anti-CD40 is an efficacious strategy for the generation of induced regulatory T2-like B cells and for the suppression of lupus in MRL/lpr mice.
about
Role of B cells in tolerance inductionDifferential impact of Toll-like receptor signaling on distinct B cell subpopulationsRegulatory functions of innate-like B cellsFibrinogen-like protein 2/fibroleukin induces long-term allograft survival in a rat model through regulatory B cellsAmyloid fibrils activate B-1a lymphocytes to ameliorate inflammatory brain diseaseIL-10 Production Is Critical for Sustaining the Expansion of CD5+ B and NKT Cells and Restraining Autoantibody Production in Congenic Lupus-Prone MiceHeterogeneity of B Cell Functions in Stroke-Related Risk, Prevention, Injury, and RepairRegulatory B10 cell development and functionSchistosomes induce regulatory features in human and mouse CD1d(hi) B cells: inhibition of allergic inflammation by IL-10 and regulatory T cellsRapamycin prevents bronchiolitis obliterans through increasing infiltration of regulatory B cells in a murine tracheal transplantation model.Autoantibody-dependent and autoantibody-independent roles for B cells in systemic lupus erythematosus: past, present, and futureThe roles of regulatory B cells in cancerProlonged effects of short-term anti-CD20 B cell depletion therapy in murine systemic lupus erythematosus.Increased levels of prolactin receptor expression correlate with the early onset of lupus symptoms and increased numbers of transitional-1 B cells after prolactin treatmentRegulatory B cells are enriched within the IgM memory and transitional subsets in healthy donors but are deficient in chronic GVHDTherapeutic targeting of Syk in autoimmune diabetesExacerbated experimental arthritis in Wiskott-Aldrich syndrome protein deficiency: modulatory role of regulatory B cellsMurine models of systemic lupus erythematosusT follicular helper cells mediate expansion of regulatory B cells via IL-21 in Lupus-prone MRL/lpr mice.Interleukin-10+ regulatory B cells arise within antigen-experienced CD40+ B cells to maintain tolerance to islet autoantigensPreferential binding to Elk-1 by SLE-associated IL10 risk allele upregulates IL10 expressionT follicular helper cells and regulatory B cells dynamics in systemic lupus erythematosus.Activated peritoneal cavity B-1a cells possess regulatory B cell properties.Regulatory B cells are identified by expression of TIM-1 and can be induced through TIM-1 ligation to promote tolerance in mice.B cell-derived IL-10 suppresses inflammatory disease in Lyn-deficient mice.The parasitic worm product ES-62 targets myeloid differentiation factor 88-dependent effector mechanisms to suppress antinuclear antibody production and proteinuria in MRL/lpr miceAntitumor effector B cells directly kill tumor cells via the Fas/FasL pathway and are regulated by IL-10B cell-derived IL-10 does not regulate spontaneous systemic autoimmunity in MRL.Fas(lpr) mice.Diversity of gut microflora is required for the generation of B cell with regulatory properties in a skin graft model.Inflammatory cell phenotypes in AAAs: their role and potential as targets for therapy.Lipopolysaccharide Attenuates CD40 Ligand-Induced Regulatory B10 Cell Expansion and IL-10 Production in Mouse Splenocytes.Interleukin-10 produced by B cells is crucial for the suppression of Th17/Th1 responses, induction of T regulatory type 1 cells and reduction of collagen-induced arthritis.Tolerant Kidney Transplant Patients Produce B Cells with Regulatory Properties.Preserving the B-cell compartment favors operational tolerance in human renal transplantation.Retention of anergy and inhibition of antibody responses during acute γ herpesvirus 68 infectionInducible IL10(+) suppressor B cells inhibit CNS inflammation and T helper 17 polarization.IL-10-produced by human transitional B-cells down-regulates CD86 expression on B-cells leading to inhibition of CD4+T-cell responses.Dimethyl fumarate treatment of relapsing-remitting multiple sclerosis influences B-cell subsets.B Cells with Regulatory Function in Human DiseasesConstitutively CD40-activated B cells regulate CD8 T cell inflammatory response by IL-10 induction
P2860
Q26824451-3D0BCB9E-C504-42DC-A985-4BE74B74665AQ26825241-B9C71DE4-3B78-4677-8A43-B2AB5B88253BQ27000352-94B85553-4589-4842-AB53-8C8AED53CEE6Q27311751-C9E825C7-6ADF-4E9E-A511-F7C67439FB9EQ27317246-EAA81823-89D1-476B-94CB-A375BE4F8F19Q27319435-799A8092-9726-42AD-B82A-2EF1CC18B273Q28078211-EB82BD8D-02DA-48FE-B3BF-90A4AE94FC1EQ28087437-22E52568-579E-490F-A332-F0C6B87631DAQ28732193-59397CAB-BC3F-4D02-A39C-46BDC7AA69ECQ30278502-D75D9585-8F5B-4BA4-BCF5-835041D406F3Q33601679-30FA9F67-EEA8-47E6-B459-C898D13DA47AQ33765986-F6A37D67-E1A7-400D-B455-D3EED1488BBBQ34063315-45014C84-CBF3-4F29-A332-E3915A0FAC27Q34190173-2DBE207B-86A4-43B0-ABE5-BB37F5A23761Q34292984-468DB61A-29C0-435C-B527-5E9F39E31EFEQ34308759-60268310-FAEA-4136-9216-BB725F4E6F50Q34406496-1840BDD4-BE76-412B-8449-75743739721BQ34591019-D11A0248-A327-4C28-9B6C-6FA4B4C4F082Q34702070-07043102-2D1E-4972-AEE7-A282CE50F139Q34762482-8CCDD1D6-353F-4CFC-91E5-86D26BFECF32Q35018126-8540371B-1A01-4CC4-A5C9-7441E68A642FQ35097391-05E18363-ED9C-44F8-9664-95E9D40A7353Q35097618-72DA1062-FB05-4A92-AE0E-6CB9691FB55BQ35187089-6A75FFE8-F836-412B-A17B-954896A60161Q35345025-4CF7392D-A0C7-466B-9326-8F37445A8E36Q35538362-06EE585C-EE2E-4881-8988-7BDAFA5D632CQ35554861-0BFDCCCB-9ABB-4AC7-8198-62A0DCADE994Q35658606-BBB0823A-05F2-447A-BDC3-CDD3ABB2C6BBQ35673671-D5833CB7-286A-4E71-B901-922A75AB2024Q35888047-0DFE1150-0366-43DD-8212-195528C187E9Q35896923-1368FAE6-1EA2-4E65-8D56-1C7A07EDC20AQ36085011-62822756-8207-4CFD-B9C0-BED4DDF260ADQ36104784-49FEC338-36B1-40E9-85D5-373739F11623Q36130967-65D14424-F463-4B2A-A593-83A8D40289CFQ36218594-CD707467-93CE-45D2-B84C-341CA08606C9Q36220700-78E6FD99-CE3F-48D4-975F-C87508A7117EQ36500626-3DF3AB5D-2D21-4FF9-B118-796C5CFBC450Q36669117-26E7B40A-6B89-4011-BAB8-244D52A9EAE3Q36677543-975FD280-B6D2-4E0A-B487-8A0C37FB6240Q36718160-6DB6B36F-02A1-45CF-B077-07BEB5C491C4
P2860
Selective targeting of B cells with agonistic anti-CD40 is an efficacious strategy for the generation of induced regulatory T2-like B cells and for the suppression of lupus in MRL/lpr mice.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Selective targeting of B cells ...... sion of lupus in MRL/lpr mice.
@en
Selective targeting of B cells ...... sion of lupus in MRL/lpr mice.
@nl
type
label
Selective targeting of B cells ...... sion of lupus in MRL/lpr mice.
@en
Selective targeting of B cells ...... sion of lupus in MRL/lpr mice.
@nl
prefLabel
Selective targeting of B cells ...... sion of lupus in MRL/lpr mice.
@en
Selective targeting of B cells ...... sion of lupus in MRL/lpr mice.
@nl
P2093
P2860
P50
P356
P1476
Selective targeting of B cells ...... sion of lupus in MRL/lpr mice.
@en
P2093
Jamie G Evans
Karina A Chavez-Rueda
Mark J Shlomchik
Paul A Blair
P2860
P304
P356
10.4049/JIMMUNOL.0803052
P407
P577
2009-03-01T00:00:00Z